Breast Cancer Update Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
Feb 24, 2023
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Introduction
00:00 • 4min
The ESR1 Mutation in the Estrogen Receptor
03:52 • 2min
Oral Serds - Can You Do Better Than Full Vestrant?
06:21 • 5min
EGFR Mutated Non Small Cell Lung Cancer
10:54 • 4min
Premenopausal Women's Cancer Panel Discussion
14:52 • 2min
Is Addis-Clin a Good Approach?
16:43 • 3min
Is Carbopladin a Part Inhibitor?
19:15 • 2min
Is There a CDK for BRCA2 Mutations?
21:10 • 3min
Breast Cancer - Is There a Survival Benefit Emerging?
23:50 • 3min
Is There an Adjuvant Trial for Breast Cancer?
27:11 • 2min
Do You See One Plus in ER Positive Breast Cancer Patients?
29:33 • 5min
Breast Cancer - Is There a Mutation?
34:10 • 4min
Do You Consider Ovarian Suspension During Chemotherapy With ER Positive Tumors?
38:18 • 2min
Cancer and Sexual Dysfunction
40:18 • 2min
Do You Want Your Ovarian Suppression to Work?
42:08 • 3min
Is There a Sexual Dysfunction?
45:33 • 4min
Can I Use Cappy Vissertib in Tumors?
49:47 • 4min
TDXD and HER2 Low Hormone Receptor Negative Breast Cancer
54:04 • 2min
Is DXD a Second Line Therapy for Lung Cancer?
56:16 • 2min
Is Chemotherapy a Good Choice for a Pre-Medopausal Patient?
58:11 • 3min
Is the CPS a BRCA Mutation?
01:00:50 • 2min